Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2023-12-06 Major Shareholding Noti…
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 9047V' and contains the standard formatting for a regulatory notification disseminated via RNS (Regulatory News Service). The content details a 'TR-1: Standard form for notification of major holdings' concerning an acquisition of voting rights by Societe Generale, crossing a threshold on 05-Dec-2023. This type of filing, reporting changes in significant share ownership, directly corresponds to the definition for Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2023-12-06 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 7685V' and contains the standard boilerplate text indicating it is provided by RNS, the news service of the London Stock Exchange. The content itself is a 'TR-1: Standard form for notification of major holdings' detailing an acquisition or disposal of voting rights by Societe Generale, crossing a threshold. This type of mandatory disclosure regarding significant changes in share ownership falls directly under the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2023-12-05 English
Form 8.3 - Dechra Pharmaceuticals plc
Major Shareholding Notification Classification · 98% confidence The document is explicitly titled "FORM 8.3 - PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE" and references "Rule 8.3 of the Takeover Code (the “Code”)". This form is used by parties involved in a takeover bid to disclose their interests and dealings in the relevant securities. This type of disclosure, related to insider transactions or significant ownership changes during a takeover scenario, aligns most closely with the definition of Director's Dealing (DIRS) or potentially a specific type of regulatory filing. However, given the specific context of takeover code disclosure regarding interests and dealings by a significant holder (Millennium International Management LP) in an offeree (Dechra Pharmaceuticals plc), it is a specialized insider/major shareholder transaction report. Since there is no specific code for 'Takeover Disclosure Form 8.3', and it details personal share transactions/holdings by an entity involved in a potential takeover, it is best categorized under Director's Dealing (DIRS) as it concerns insider/significant shareholder transactions, or as a general Regulatory Filing (RNS). Given the highly specific nature of the form (Rule 8.3), which is distinct from standard director's dealing reports (like Form 3/4/5 in the US context), and its focus on takeover activity, it is a specialized regulatory disclosure. In the provided list, 'DIRS' covers personal share transactions by directors/executives, and 'RNS' is the general regulatory fallback. Since this is a mandatory disclosure related to a takeover bid, it is a specific regulatory filing. However, if we must choose the closest fit among the options, 'DIRS' covers personal share transactions by executives/directors, and this form details the position and dealings of a major shareholder/stakeholder during a takeover. Given the options, 'DIRS' is a plausible fit for significant transaction reporting, but 'RNS' (Regulatory Filings) is the safest fallback for a specific, non-standard regulatory form like Form 8.3. Let's re-evaluate the options: DIRS is for directors/executives. This is Millennium International Management LP. It is a major shareholder disclosure during a takeover. This is closer to Major Shareholding Notification (MRQ) or a general Regulatory Filing (RNS). Since it is a mandatory disclosure under the Takeover Code, RNS is the most appropriate general regulatory category when a specific takeover filing code is missing. I will classify it as RNS as it is a mandatory regulatory filing under the Takeover Code.
2023-12-05 English
Form 8.3 - Dechra Pharmaceuticals plc
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'FORM 8.3 - Dechra Pharmaceuticals plc' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. This form is a Public Opening Position Disclosure/Dealing Disclosure by a person with interests in relevant securities representing 1% or more, typically filed during a takeover situation. This type of filing relates to insider transactions or significant ownership changes during a takeover bid, which falls under the scope of M&A activity or specific regulatory disclosures related to takeovers. Since there is no specific code for 'Takeover Disclosure', and it details dealings by a major shareholder/stakeholder during a potential M&A event concerning Dechra Pharmaceuticals plc, the closest fit among the provided options is 'M&A Activity' (TAR), as it directly concerns a transaction/stakeholding related to a takeover scenario. However, given the highly specific nature of Form 8.3 as an insider/major shareholder dealing disclosure under the Takeover Code, and the lack of a dedicated code for this specific regulatory filing type, it is best classified under the general regulatory/transactional category. Since it is a mandatory disclosure related to a takeover/merger situation, TAR (M&A Activity) is the most contextually relevant choice, although DIRS (Director's Dealing) is related to insider transactions, Form 8.3 is broader and tied to the takeover process. Given the context of the Takeover Code, TAR is the most appropriate classification for disclosures made during an active offer period.
2023-12-04 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 6043V' and contains the standard formatting and concluding remarks associated with RNS (Regulatory News Service) announcements from the London Stock Exchange. The content itself is a 'TR-1: Standard form for notification of major holdings,' which details changes in share ownership by an institutional investor (UBS Group AG). This type of filing, reporting changes in significant shareholdings that cross or fall below reporting thresholds, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is an RNS filing, MRQ is the more specific category for this content type.
2023-12-04 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with "RNS Number : 5666V" and contains the standard header/footer information associated with RNS (Regulatory News Service) announcements from the London Stock Exchange. The content details a "TR-1: Standard form for notification of major holdings" by Societe Generale regarding an acquisition/disposal of voting rights in Dechra Pharmaceuticals PLC, crossing a threshold on 01-Dec-2023. This type of mandatory disclosure regarding significant changes in share ownership directly corresponds to the definition of Major Shareholding Notification (MRQ). Although RNS is a general category, MRQ is more specific and accurate for this content.
2023-12-04 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.